OpenAlex
Works that cite this article, indexed by OpenAlex.
Cyclic nucleotide phosphodiesterases as drug targets
Pharmacological Reviews 77(3) (2025)
Michy P. Kelly; Viacheslav O. Nikolaev; Leila Gobejishvili; Claire Lugnier; Christian Heßlinger; Peter Nickolaus; David A. Kass; Walma Pereira de Vasconcelos; Rodolphe Fischmeister; Stefan Brocke; Paul M. Epstein; Gary Anthony Piazza; Adam B. Keeton; Gang Zhou; Mohammad Abdel‐Halim; Alireza Abadi; George S. Baillie; Mark A. Giembycz; Graeme B. Bolger; Gretchen L. Snyder; Kjetil Taskén; Nathaniel Edward Bennett Saidu; Martina Schmidt; Manuela Zaccolo; RALPH THEO SCHERMULY; Hengming Ke; Rick Cote; Soroush Mohammadi Jouabadi; Anton J.M. Roks
NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer
International Journal of Molecular Sciences 25(11) (2024)
Leandro L. Coutinho; Elise L. Femino; Ana L. González; Rebecca L. Moffat; William F. Heinz; Robert Y.S. Cheng; Stephen Lockett; María Cristina Rangel; Lisa A. Ridnour; David A. Wink
Naringenin: A potential anticancer drug
Results in Chemistry 16 (2025)
Yi Zhang; Haixin Ding; Xue Zhao; Yutong Li; Pengling Ge
Inflammation and carcinogenesis: molecular targets and small-molecule intervention strategies
Journal of Enzyme Inhibition and Medicinal Chemistry 41(1) (2026)
Wan‐Jung Lu; Ritu Ojha; Mandeep Rana; Vinod Gautam; Jiun-Yi Li; Shao-An Wang
Comprehensive analysis of PDE2A: a novel biomarker for prognostic value and immunotherapeutic potential in human cancers
Brazilian Journal of Medical and Biological Research 57 (2024)
Zhen Yu; Yawen Song; Jin Wang; Yujing Wu; He‐Fang Wang; ShuYe Liu; Yu Ting Zhu
Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors
Biochemical and Biophysical Research Communications 733 (2024)
Ming Wang; Qiuyuan Deng; Wei Zhang; Qing Qi